Vanguard Personalized Indexing Management LLC Purchases 8,421 Shares of UnitedHealth Group Incorporated $UNH

Vanguard Personalized Indexing Management LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 108,919 shares of the healthcare conglomerate’s stock after acquiring an additional 8,421 shares during the quarter. UnitedHealth Group accounts for about 0.4% of Vanguard Personalized Indexing Management LLC’s holdings, making the stock its 28th largest position. Vanguard Personalized Indexing Management LLC’s holdings in UnitedHealth Group were worth $37,635,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of UNH. Geode Capital Management LLC boosted its position in shares of UnitedHealth Group by 3.3% during the 2nd quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate’s stock valued at $6,624,411,000 after acquiring an additional 675,075 shares in the last quarter. Norges Bank bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $3,837,207,000. Dodge & Cox lifted its position in shares of UnitedHealth Group by 117.7% during the 2nd quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate’s stock worth $2,729,912,000 after buying an additional 4,730,192 shares during the period. Charles Schwab Investment Management Inc. grew its position in UnitedHealth Group by 6.1% in the second quarter. Charles Schwab Investment Management Inc. now owns 7,502,469 shares of the healthcare conglomerate’s stock valued at $2,340,346,000 after acquiring an additional 432,084 shares during the period. Finally, Amundi lifted its holdings in shares of UnitedHealth Group by 33.8% during the second quarter. Amundi now owns 6,191,871 shares of the healthcare conglomerate’s stock valued at $1,904,372,000 after acquiring an additional 1,565,245 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on UNH. The Goldman Sachs Group started coverage on shares of UnitedHealth Group in a report on Tuesday, October 14th. They set a “buy” rating and a $406.00 price target for the company. Leerink Partners set a $410.00 price target on UnitedHealth Group and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Morgan Stanley reduced their price objective on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a research note on Friday. Wells Fargo & Company raised their target price on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Finally, Mizuho increased their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $386.33.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $356.46 on Monday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The company’s 50-day moving average is $332.07 and its two-hundred day moving average is $323.59. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. The company has a market cap of $322.89 billion, a PE ratio of 18.60, a PEG ratio of 2.15 and a beta of 0.42.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period in the prior year, the business posted $7.15 earnings per share. UnitedHealth Group’s revenue was up 12.2% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s dividend payout ratio is currently 46.14%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.